RobertWilliamTofteMD

PubMed

• High-Dose Moxalactam in Gram-Negative Pneumonia:
  Bruce H. Ackerman, John C. Rotschafer, Robert W. Tofte> ;Drug Intelligence & Clinical Pharmacy. 1986 Jan 1
• 1 citations
  Rifampin. No longer just for tuberculosis.
  Robert W. Tofte> ;Postgraduate Medicine. 1985 Feb 15
• 26 citations
  Susceptibilities of enterococci to twelve antibiotics.
  R W Tofte, J A Solliday, Kent B. Crossley> ;Antimicrobial Agents and Chemotherapy. 1984 Apr 1
• 12 citations
  Aeromonas hydrophila wound infection of the hand initially presenting as clostridial myonecrosis
  Harley S. Geller, Robert W. Tofte, Bruce L. Cunningham> ;The Journal of Hand Surgery. 1983 May 1
• 23 citations
  Ceftriaxone therapy of serious bacterial infections in adults.
  M. J. Bittner, D. L. Dworzack, Laurel C. Preheim, Robert W. Tofte, Kent B. Crossley> ;Antimicrobial Agents and Chemotherapy. 1983 Feb 1
• 4 citations
  Clinical use of a one-compartment model for determining netilmicin pharmacokinetic parameters and dosage recommendations
  John C. Rotschafer, Kent B. Crossley, Darwin E. Zaske, N. J. Russillo, Richard G. Strate, Robert W. Tofte, Lynn D. Solem> ;Therapeutic Drug Monitoring. 1983 Jan 1
• 7 citations
  Toxic shock syndrome.
  Robert W. Tofte, David N. Williams> ;Postgraduate Medicine. 1983 Jan 1
• 92 citations
  Toxic Shock Syndrome: Clinical, Laboratory, and Pathologic Findings in Nine Fatal Cases
  Stephen M. Larkin, David N. Williams, Michael T. Osterholm, Robert W. Tofte, Zoltan Posalaky> ;Annals of Internal Medicine. 1982 Jun 1
• 47 citations
  Toxic Shock Syndrome: Management and Long-Term Sequelae
  P. Joan Chesney, Barbara A. Crass, Marcia B. Polyak, Philip J. Wand, Thomas F. Warner, James M. Vergeront, Jeffrey P. Davis, Robert W. Tofte, Russell W. Chesney, Merli...> ;Annals of Internal Medicine. 1982 Jun 1
• 44 citations
  Clinical and Laboratory Manifestations of Toxic Shock Syndrome
  Robert W. Tofte, David N. Williams> ;Annals of Internal Medicine. 1982 Jun 1
• 6 citations
  Aminoglycoside dosing in renal transplant patients. Comparison of nomogram and individualized pharmacokinetic methods in patients with shifting renal function.
  Robert W. Tofte, Daniel M. Canafax, Richard L. Simmons, Phillip K. Peterson> ;Annals of Surgery. 1982 Mar 1
• 24 citations
  Moxalactam therapy for a wide spectrum of bacterial infections in adults.
  Robert W. Tofte, John C. Rotschafer, J. Solliday, Kent B. Crossley> ;Antimicrobial Agents and Chemotherapy. 1981 May 1
• 26 citations
  Primary cutaneous Nocardia asteroides infection with dissemination
  Frederick W. Kahn, Charles C. Gornick, Robert W. Tofte> ;The American Journal of Medicine. 1981 Apr 1
• 3 citations
  Antibiotic-associated colitis during moxalactam therapy.
  Robert W. Tofte> ;The Journal of Antimicrobial Chemotherapy. 1981 Apr 1
• 86 citations
  Toxic Shock Syndrome: Clinical and Laboratory Features in 15 Patients
  Robert W. Tofte, David N. Williams> ;Annals of Internal Medicine. 1981 Feb 1
• 8 citations
  Staphylococcus aureus infection of dialysis shunt: absence of synergy with vancomycin and rifampin.
  Robert W. Tofte, Joanne Solliday, John C. Rotschafer, Kent B. Crossley> ;Southern Medical Journal. 1981 Jan 1
• 6 citations
  Clinical experience with toxic-shock syndrome.
  Robert W. Tofte, Kent B. Crossley, David N. Williams> ;The New England Journal of Medicine. 1980 Dec 11
• 2 citations
  Antimicrobial susceptibility of Acinetobacter calcoaceticus, Serratia marcescens, Pseudomonas fluorescens and Pseudomonas maltophilia to three novel cephalosporin-like...
  Robert W. Tofte, Kent B. Crossley> ;The Journal of Antimicrobial Chemotherapy. 1980 Nov 1
• 79 citations
  Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
  Robert W. Tofte, Phillip K. Peterson, David Schmeling, James W. Bracke, Youngki Kim, Paul G. Quie> ;Infection and Immunity. 1980 Mar 1
• 16 citations
  Influence of serum concentration on opsonization by the classical and alternative complement pathways.
  Robert W. Tofte, Phillip K. Peterson, Youngki Kim, Paul G. Quie> ;Infection and Immunity. 1980 Feb 1
• 28 citations
  Opsonic Activity of Normal Human Cerebrospinal Fluid for Selected Bacterial Species
  Robert W. Tofte, Paul G. Quie, > ;Infection and Immunity. 1979 Dec 1
• Toxic shock syndrome. Evidence of a broad clinical spectrum.
  Tofte, R. W., Williams, D. N.> ;JAMA. 1981 Nov 13
• Toxic shock syndrome: current status and future prospects.
  Tofte, R. W., Williams, D. N.> ;Minn Med. 1981 Aug
• Effect of decreased renal function on the pharmacokinetics of ceftazidime.
  Ackerman, B. H., Ross, J., Tofte, R. W., Rotschafer, J. C.> ;Antimicrob Agents Chemother. 1984 Jun
• [Haukeland Nursing School''s 75th anniversary: from "watch women" to modern nursing].
  Tofte, R.> ;Sykepleien. 1983 Jun 20
• Join now to see all